AMPH
Amphastar Pharmaceuticals, Inc.
26.30$
+5.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35.6% | 13.4% | 32.2% | 37.9% | 31.8% | 15.6% | 20.6% | 20.4% | 27.4% | 17.9% | 27.9% | 27.9% | 25.3% | |
| 7.5% | 7.7% | 8.1% | 7.8% | -2.2% | 7.9% | 8.9% | 7.5% | 7.4% | 8.7% | 8.4% | 10.1% | 8.6% | |
| 2.6% | 2.6% | 4.3% | 3.2% | 3.0% | 3.0% | 4.9% | 3.7% | 3.3% | 3.4% | 5.4% | 3.9% | 4.0% | |
| -3.2% | -15.0% | -4.2% | 4.7% | -3.9% | -4.6% | -9.8% | -10.6% | 6.3% | -23.3% | 8.9% | -1.4% | -2.5% | |
| 5.6% | 5.3% | 5.1% | 3.3% | 7.3% | 6.7% | 6.3% | 6.1% | 2.8% | 4.5% | 5.6% | 4.7% | 4.3% | |
| -17.3% | -57.9% | 8.9% | -38.3% | -18.3% | -19.1% | 6.1% | -0.4% | -10.2% | -33.1% | -9.8% | 24.4% | -7.1% | |
| 1.2% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -27.7% | 32.6% | -10.1% | -4.7% | -18.5% | -22.5% | -6.5% | -22.5% | 26.2% | -11.2% | -17.2% | -24.6% | -6.2% | |
| – | – | – | – | 5.0% | 2.5% | 0.9% | 2.3% | 0.1% | 0.1% | 0.0% | -0.3% | 0.0% | |
| 48.0% | -26.4% | -7.9% | -5.9% | -12.1% | -18.1% | -8.5% | -17.3% | -2.3% | -10.0% | -17.6% | -23.7% | -13.2% | |
| 66.3% | -71.0% | 33.1% | -6.3% | 1.3% | -21.7% | 18.3% | 2.8% | 14.9% | -25.2% | 0.4% | 28.6% | 4.9% | |
| 30.0% | 8.1% | 27.1% | 34.6% | 24.5% | 8.9% | 14.3% | 14.3% | 24.6% | 13.4% | 22.4% | 23.2% | 20.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.